Elephant vaccine shows first signs of protection against deadly virus
Peer-Reviewed Publication
Updates every hour. Last Updated: 26-Oct-2026 02:17 ET (26-Oct-2026 06:17 GMT/UTC)
Adults with kidney transplants who were treated for COVID-19 with the antiviral remdesivir within a week of COVID-19 diagnosis and who received at least three consecutive days of therapy were less likely than kidney transplant recipients who did not receive the antiviral to experience cardiovascular or kidney problems up to a year later, according to findings from a target trial emulation study that published in JAMA Network Open.
A new quantum sensing technique could enable measurements of single protein structures and other important molecules, with potential applications in drug discovery and structural biology.
The research team from the Institute for Quantum Computing (IQC) at the University of Waterloo developed the new method that uses a single molecule as a quantum sensor. Quantum sensors use unique properties of quantum mechanics to make ultra-precise measurements that traditional sensors cannot achieve.
A new treatment combining THC and CBD significantly reduced agitation in people with late-stage Alzheimer’s and other dementias who were eligible to receive or received hospice care, with benefits seen in two weeks.
Nearly 9-in-10 study participants who received the treatment showed overall improvement in target symptoms at study end at Week 12.
The LiBBY study demonstrates that dementia patients at late stages of their illness can participate in clinical trials, helping expand much-needed clinical research.
Biosensors have revolutionized home healthcare over the last two decades. Devices like wearable heart rate and blood glucose monitors are giving people with chronic health conditions the information and assurance they need to maintain an active lifestyle. But even the best sensors are limited by their ability to sustain skin contact through the rigors of physical activity. Researchers from Drexel University and Penn State University took on the challenge of improving the hydrogel material used in biosensors. And, in recently published research, they reported a new formula for making the gelatinous substrate that is versatile, durable and adhesive enough to make a stronger connection.
A randomized clinical trial conducted in India by Indian and Norwegian researchers demonstrates that an integrated intervention package improves growth and neurodevelopment in babies born to small, so-called Small-for-Gestational Age (SGA) infants. The results of the study were published in JAMA (Journal of the American Medical Association, one of the world's leading medical journals) on 27 July 2026.